Globeflex Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
167,515
+115,220
| +220% | +$2.16M | 0.26% | 95 |
|
|
2025
Q1 | $941K | Hold |
52,295
| – | – | 0.09% | 174 |
|
|
2024
Q4 | $880K | Buy |
52,295
+43,095
| +468% | +$725K | 0.07% | 203 |
|
|
2024
Q3 | $149K | Buy |
+9,200
| New | +$149K | 0.01% | 341 |
|
|
2016
Q3 | – | Sell |
-33,953
| Closed | -$757K | – | 536 |
|
|
2016
Q2 | $757K | Sell |
33,953
-11,000
| -24% | -$245K | 0.21% | 186 |
|
|
2016
Q1 | $935K | Buy |
+44,953
| New | +$935K | 0.25% | 142 |
|